Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Scientific Interest Group
“Of the many mysterious human illnesses that science has yet to unravel, ME/CFS has proven to be one of the most challenging,”
NIH Director Francis S. Collins, M.D., Ph.D.
In October 2015, the NIH announced new intramural and extramural initiatives to determine the cause of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and identify clinically meaningful treatments.1 Recent efforts to describe ME/CFS have identified ‘post-exertional malaise’ as the key defining symptom of ME/CFS.2 While the serious, debilitating impact of ME/CFS symptoms have on the estimated one million afflicted Americans is self-evident, there remains much controversy over its potential cause. To date, there is no experimental evidence proving causality that has withstood scientific scrutiny.
The ME/CFS SIG seeks to provide a forum in which to disseminate and discuss clinical and scientific information about ME/CFS. It is open to all interested intramural and extramural investigators seeking to learn more about ME/CFS and hopes to foster new research collaborations across the NIH campus. The SIG is led by Avi Nath, the NINDS Clinical Director and Primary Investigator of the Intramural ME/CFS initiative, and is moderated by his Lead Associate Investigator, Brian Walitt. The ME/CFS SIG will present a bimonthly seminar series with internal and outside experts and may include additional lectures, seminars, panel discussions, journal discussions, poster sessions, and other opportunities to facilitate discussion and collaboration.
To join the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Scientific Interest Group mailing list, please visit the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Scientific Interest Group Listserv home page, then click the “Subscribe or Unsubscribe” link in the right sidebar.
Scientific Focus Areas
This page was last updated on Thursday, August 12, 2021